The 6 key players our Regenerative Medicine report profiles.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Gilead Sciences, Inc. |
gilead.com (opens in a new tab) | 347 reports |
| 2 | Novartis AG |
novartis.com (opens in a new tab) | 1,651 reports |
| 3 | Vertex Pharmaceuticals | — | 314 reports |
| 4 | Smith & Nephew |
smith-nephew.com (opens in a new tab) | 512 reports |
| 5 | Organogenesis | — | 149 reports |
| 6 | Integra Life Sciences Corporation |
integra.com (opens in a new tab) | 232 reports |
One report for each place. Each tile opens that place's report.
Compare all 50 places for Regenerative Medicine, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.